Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-20

Clinical Trial Update: Sertaconazole 2% Cream to Improve Symptoms Associated With Atopic Dermatitis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating sertaconazole 2% cream for improving symptoms associated with atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sertaconazole 2% Cream (sertaconazole)

Snippet

Sponsor: Spirig Pharma Ltd. | Conditions: Skin Alterations Associated With Atopic Dermatitis | Phase 2 | Status: COMPLETED